Lombard Medical

Lombard Medical, Inc. is an Irvine, CA-based medical device company focused on the $1.6bn market for minimally invasive treatment of abdominal aortic aneurysms (AAAs). The Company has global regulatory approval for Aorfix™, an endovascular stent graft which has been specifically designed to treat patients with the broadest range of AAA anatomies, including aortic neck angulation up to 90 degrees. The Company has also achieved CE Mark for the Altura™ endograft system, an innovative ultra-low profile endovascular stent graft that offers a simple and predictable solution for the treatment of more standard AAA anatomies. Altura will be launched in Europe in January 2016, with an international rollout planned for later in 2016.
Company Growth (employees)
Type
Public
HQ
Oxfordshire, GB
Size (employees)
111 (est)
Lombard Medical is headquartered in Oxfordshire, GB

Lombard Medical Office Locations

Lombard Medical has an office in Oxfordshire

Lombard Medical Metrics

Lombard Medical Financial Metrics

Net income (2015)

(£62.6 m)

Market capitalization (28-Apr-2017)

$10.4 m

Closing share price (28-Apr-2017)

$0.5

Cash (31-Dec-2015)

£3.8 m
Lombard Medical's current market capitalization is $10.4 m.
Lombard Medical's revenue was reported to be £2.9 m in FY, 2014
FY, 2013FY, 2014FY, 2015

Revenue

£2.3 m£2.9 m

Revenue growth, %

25%

Pre tax profit

(£719 k)(£1.6 m)(£62.6 m)

Net Income

(£743 k)(£1.6 m)(£62.6 m)
FY, 2013FY, 2014FY, 2015

Cash

£23.5 m£23.8 m£3.8 m

Current Assets

£24.3 m£23.9 m£26.5 m

PP&E

£60.9 m£82.7 m£2.1 m

Total Assets

£85.2 m£106.6 m£28.6 m

Accounts Payable

£147 k£21 k£297 k

Current Liabilities

£1.3 m£412 k£8.2 m

Retained Earnings

(£743 k)(£1.6 m)(£62.6 m)

Total Equity

£82.4 m£81.1 m£18.5 m

Financial Leverage

1 x1.3 x1.5 x
FY, 2013FY, 2014

Cash From Operating Activities

£347 k(£1.5 m)

Cash From Financing Activities

£36 m£23.4 m

Income Taxes Paid

(£24 k)

Lombard Medical Market Value History

Lombard Medical Company Life

You may also be interested in